載入...
Aptamer‐targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7‐positive tumours
OBJECTIVES: Aptamer sgc8c is a short DNA sequence that can target protein tyrosine kinase 7 (PTK7), which was overexpressed on many tumour cells. This study aimed to fabricate a novelty DNA nanostructure drug delivery system target on PTK7‐positive cells—CCRF‐CEM (human T‐cell ALL). METHODS: Aptamer...
Na minha lista:
| 發表在: | Cell Prolif |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430458/ https://ncbi.nlm.nih.gov/pubmed/30311693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12511 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|